Friday 28 November 2014

Melanoma & Skin Cancer News Round Up: 28/11/2014



MASScot does not endorse nor is affiliated with any of the content contained within these links.



  • Rare condition forces three-year-old Eddison to be 'boy in the bubble'

The family of a three-year-old boy diagnosed with an incurable condition which makes him 10,000 times more likely to develop skin cancer have reached out to other families coping with the disorder.

Source: STV 


  • How selenium in broccoli may fight melanoma

The mineral selenium, which naturally occurs in foods like broccoli and garlic, appears to slow down a process that allows cancers such as melanoma, prostate cancer, and leukemia to spread.


Source: Futurity 


  • US Skin Cancer Costs Top $8 Billion Annually (USA)

Each year in the United States, nearly 5 million people are treated for skin cancer, at a cost of $8.1 billion dollars. The costs associated with skin cancer treatment are not only rising, but they are increasing substantially more than for other cancers.

Source: Medical Research 


  • UCLA study paves the way to more effective melanoma treatment


Last September, the Food and Drug Administration (FDA) approved pembrolizumab, which was found to be affective against melanoma, a deadly form of skin cancer. Sadly, not all melanoma patients benefit from the treatment and UCLA Jonsson Comprehensive Cancer Center investigators have determined a method that will predict which patients will respond to the drug. Their research should lead to more effective treatment of melanoma patients. The findings of the two year study were published online on November 26 in the journal Nature.

Source: Examiner 

No comments:

Post a Comment